SCHEMBL11825334

SCHEMBL11825334

COCCN(CCOC)S(=O)(=O)c1ccc(SCc2cccc(Br)c2)c(C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ CA2 P00918 3/20 0.41
▸ CA4 P22748 2/20 0.41
▸ PTPRG P23470 2/20 0.39
▸ VCAM1 P19320 1/20 0.39
▸ LMNA P02545 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ PTPRC P08575 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ TAS2R14 Q9NYV8 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11821631 0.90 CA2 (0.49) KMT2AMEN1HTTCA2CA4
SCHEMBL11815898 0.89 PTPRG (0.46) KMT2AMEN1CA2CA4PTPRG
SCHEMBL11819918 0.88 KMT2A (0.47) KMT2AMEN1HTTCA2CA4
SCHEMBL11821805 0.86 KMT2A (0.45) KMT2AMEN1HTTCA2CA4
SCHEMBL11825369 0.86 KMT2A (0.45) KMT2AMEN1HTTCA2CA4
SCHEMBL11820863 0.85 KMT2A (0.48) KMT2AMEN1HTTCA2CA4
SCHEMBL11819740 0.83 VCAM1 (0.40) HTTCA2CA4PTPRGVCAM1
SCHEMBL11825881 0.83 TAS2R14 (0.43) KMT2AMEN1HTTCA2CA4
SCHEMBL11813988 0.82 TAS2R14 (0.45) KMT2AMEN1HTTVCAM1LMNA
SCHEMBL11816192 0.81 MAPT (0.48) KMT2AMEN1HTTVCAM1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954994-A Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents PFIZER INC. (US) 1976-05-04 — — US disclosed
Send feedback